Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying the best management approach for uncomplicated acute small bowel obstruction aSBO, a condition where the small intestine is blocked. Traditionally, non-surgical treatment lasting 72 hours is recommended before considering surgery, but this is only successful in about 60 to 70% of cases. Early surgery within 24 hours is being evaluated as it may reduce complications, hospital stay length, and improve surgical outcomes due to advances in laparoscopic techniques and anesthesia. The study compares two treatment strategies. One group receives standard care involving a nasogastric tube and hydration for 72 hours before surgery is considered if symptoms do not improve. The experimental groups treatment is guided by a radiological score that predicts treatment success patients with a high score 5 receive early surgery within 24 hours, starting laparoscopically with conversion to open surgery if needed. Those with a low score <5 receive the standard 72-hour medical management. Participants are monitored daily during their hospital stay for surgery details, medical management success, gastrointestinal recovery, and any complications. Follow-up visits occur 30 and 90 days post-surgery to track morbidity, mortality, and recurrence. Additionally, participants receive a telephone follow-up at 12 months to assess any further episodes of obstruction. The primary outcome is 90-day morbidity and mortality related to the management strategy.
Actively Recruiting
Researchers are studying the care pathways of 300 adult patients diagnosed with anal squamous cell carcinoma to identify barriers and delays in diagnosis. The study aims to assess waiting times for consultations, evaluate potential fast-track diagnostic options, and analyze the role of screening and access to care. It also seeks to understand patient reluctance, socio-economic impacts, and knowledge about the link between HPV and anal cancer to enhance awareness and early diagnosis. Participants will complete a self-administered questionnaire to provide information about their care journey, difficulties encountered, and understanding of HPVs role in anal cancer. The study will analyze how many cancers were diagnosed through screening and how many eligible patients missed screening opportunities. This observational study does not involve treatments but focuses on evaluating diagnostic and care processes. Throughout the study, researchers will collect data on first symptoms and histological diagnosis, tumor staging, health inequalities, HPVs connection to anal cancer, and whether rectal exams were performed at first consultations. This data will help improve public and healthcare professional awareness and support earlier diagnosis. The study is expected to run until the end of 2028, with participant involvement mainly through questionnaire completion and medical record analysis.